Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Hepatogastroenterology ; 49(45): 844-6, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12064004

RESUMEN

In this report, a unique case of a localized (T1N0M0) adenocarcinoma of the head of the pancreas is presented, which was successfully treated with interstitial high dose rate brachytherapy combined with percutan irradiation after biopsy. A total dose of 18 Gy was delivered with brachytherapy (6 Gy per fraction on three consecutive days) to the tumor via after-loading catheter. Brachytherapy was followed by external radiotherapy, delivering an additional dose of 46 Gy (18 MV-x) with four-field technique using conventional fractionation (2 Gy/day). Thirty-six months after completion of the treatment the patient is alive with no evidence of disease. The combination of interstitial high dose rate brachytherapy and external beam radiation therapy may be an effective tool to deliver curative dose without any significant sequelae in the treatment of operable pancreatic carcinoma, when the patient's condition contraindicates surgery.


Asunto(s)
Adenocarcinoma/radioterapia , Braquiterapia , Neoplasias Pancreáticas/radioterapia , Adenocarcinoma/diagnóstico por imagen , Humanos , Masculino , Persona de Mediana Edad , Neoplasias Pancreáticas/diagnóstico por imagen , Dosificación Radioterapéutica , Tomografía Computarizada por Rayos X
2.
Magy Onkol ; 47(2): 161-3, 2003.
Artículo en Húngaro | MEDLINE | ID: mdl-12975663

RESUMEN

AIM: To present a unique case of an early (T1N0M0) adenocarcinoma of the head of the pancreas, which was successfully treated with radiotherapy alone. MATERIAL AND METHOD: After the computer tomography operated histological verification the combination of interstitial high dose rate after-loading brachytherapy (18 Gy, 6 Gy/die) and percutan irradiation (46 Gy) was applied. RESULT: Fifty-two months after completion of the treatment the patient is alive with no evidence of disease. CONCLUSION: The combination of these therapeutic modalities may be an effective tool to deliver curative dose without any significant sequelae in the treatment of operable pancreatic carcinoma, when the patient's condition contraindicates surgery.


Asunto(s)
Adenocarcinoma/radioterapia , Braquiterapia , Neoplasias Pancreáticas/radioterapia , Adenocarcinoma/patología , Adulto , Humanos , Masculino , Estadificación de Neoplasias , Neoplasias Pancreáticas/patología , Dosificación Radioterapéutica , Planificación de la Radioterapia Asistida por Computador , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA